% Expired Patents = 16.7

EPO Patents = 1

Forward Citations = 4

Loading Chart...

4 inventors (with patents filed for the assignee):

Harold C Smith (6 out of 12 patents)

Ryan P Bennett (5 out of 6 patents)

Peter B Jahrling (1 out of 5 patents)

4. Hui Zhang (1 out of 5 patents)

6 patents: Sort by Forward Citations

1. 11779585 - Method for treating coronavirus infections (2023-10-10),

2. 11738025 - Method for treating coronavirus infections (2023-08-29),

3. 11617753 - Methods of treating and inhibiting Ebola virus infection (2023-04-04),

4. 11116762 - Compounds, compositions, and methods for treating human immunodeficiency virus (2021-09-14),

5. 10588902 - Camptothecin derivatives as anti-HIV agents and methods of identifying agents that disrupt Vif self-association (2020-03-17),

6. 8334255 - Peptide and treatment for HIV-1 infection (2012-12-18),

Oyagen, Inc. is a leading biotechnology company focused on developing innovative solutions for the healthcare industry. With a strong emphasis on research and development, Oyagen is committed to creating cutting-edge products to improve patient outcomes and quality of life. Their team of experts are dedicated to advancing the field of biotechnology and making a positive impact on global health.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

6 Patents

#101 in Rochester, NY

#2,692 in New York

#44,871 in US

Rochester, NY, United States of America

Oyagen, Inc.

Forward Citations = 4

4 inventors:

Harold C Smith (6 out of 12 patents)

Ryan P Bennett (5 out of 6 patents)

Peter B Jahrling (1 out of 5 patents)

4. Hui Zhang (1 out of 5 patents)

Please report any incorrect information to [email protected]

1 patent (EPO):

Please report any incorrect information to [email protected]